FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Triamcinolone Acetonide Injection
Status: Currently in Shortage
»Date first posted: 09/27/2021
»Therapeutic Categories: Ophthalmology

Harrow Eye, LLC (Revised 03/05/2024)

Company Contact Information:
(615) 733-4734

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Triesence, Injection, 40 mg/1 mL (NDC 0065-0543-01)	Unavailable	Estimated shortage duration: 3-18 months. There are no therapeutic equivalents.	Requirements related to complying with good manufacturing practices